This clinical trial will investigate a potential treatment option for coeliac disease. The only effective treatment currently available for coeliac disease is a strict, lifelong, gluten-free diet. With gluten being present in a variety of food and drinks, this study brings hope to people suffering with this disease. This study will assess the safety and tolerability of a potential new oral treatment (IMU-856) when given to people with coeliac disease. This treatment works by blocking a protein found in the gut, which is believed to play an important role in strengthening the delicate lining of the gut in order to prevent damage that might cause an inflammatory reaction. This could potentially improve quality of life for people with coeliac disease.

Our goals:

• Research into faster and more accurate diagnosis
• Improve understanding around the causes of disease and better prediction of disease progression
• Increase survival and quality of life for patients and families